DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 01 · Volume 46 · Januar 2013 DOI: 10.1055/s-002-24306

AGNP News

I
AGNP-Preis für Forschung in der Psychopharmakologie

Original Paper

1
von Wilmsdorff, M.; Bouvier, M.-L.; Henning, U.; Schmitt, A.; Schneider-Axmann, T.; Gaebel, W.: The Sex-Dependent Impact of Chronic Clozapine and Haloperidol Treatment on Characteristics of the Metabolic Syndrome in a Rat Model
10
Benninghoff, J.; Grunze, H.; Schindler, C.; Genius, J.; Schloesser, R. J.; van der Ven, A.; Dehning, S.; Wiltfang, J.; Möller, H.-J.; Rujescu, D.: Ziprasidone – Not Haloperidol – Induces more de-novo Neurogenesis of Adult Neural Stem Cells Derived from Murine Hippocampus
16
Laux, G.; Friede, M.; Müller, W. E.: Treatment of Comorbid Anxiety and Depression with Escitalopram: Results of a Post-Marketing Surveillance Study
23
Bliznak, L.; Berg, R.; Häge, A.; Dittmann, R. W.: High Rate of Non-Eligibility: Methodological Factors Impacting on Recruitment for a Multicentre, Double-Blind Study of Paediatric Patients with Major Depressive Disorder
29
Hochstrasser, T.; Ehrlich, D.; Sperner-Unterweger, B.; Humpel, C.: Antidepressants and Anti-Inflammatory Drugs Differentially Reduce the Release of NGF and BDNF from Rat Platelets

Letter

35
Bonnet, U.: Chronic Cannabis Abuse, Delta-9-tetrahydrocannabinol and Thyroid Function
36
Chapelle, C.; Quenet, S.; Delavenne, X.; Lacut, K.; Mismetti, P.; Laporte, S.; Beyens, M. N.: Antipsychotics: A Real or Confounding Risk Factor for Venous Thromboembolism?
37
Delić, M.; Pregelj, P.: Delirium during i. v. Citalopram Treatment: A Case Report
39
Gahr, M.; Kölle, M. A.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.: Aseptic Gingivitis Related to Quetiapine Hemifumarate